RE:Fundamentals intact, Tax Loss/Reg A selling Steve, I am new to DPRO and this bullboard. THANK YOU for being one of the few commenters on Stockhouse re DPRO. I am a retired fee only money manager in the US. I have another small Canadian stock that I bought at .30 in 2014, it went to $11 (US) but experience lab contamination and in 2018 and now back to $3.20 (US). I plan on looking at DPRO finances more closely in January. On top of the FDA closing TH down for awhile, TH also down for the same technical and tax loss harvesting. TH (Theratech.com) is into Phase III, fast tracked for cancer treatments, given fast track by the FDA. So, I know about year end micro-cap selling for losses. Believe me, here in the US we ALL look for stocks that are down due to year-end selling. I expect this stock to at least triple in the first six months of 2022. I could see DPRO maybe doubling next year, depending upon if they can fullfil all their new business contracts.